Key Drivers
- Thin Margins
- Weak Coverage
- Steady Cash
AIAI Summary
DBD has shifted from a survival story to a cash-flow recovery story, with six straight quarters of positive FCF and improving demand/backlog, but the stock likely stays capped until management proves margin expansion can outpace its still-meaningful leverage and weak interest coverage.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Thin Margins
- •Weak Coverage
- •Steady Cash
DBD generates solid cash flow but its thin margins, weak interest coverage, and moderate leverage make it a cautious hold rather than a compelling buy.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Broken support
- •Base watch
Over the last month, DBD has dropped 21.5% into a clear short-term downtrend with lower highs/lower lows, leaving $69.70 as near-term support and $75-$78, then $82-$85, as overhead resistance.
Failed at $82-$85 and broke below $75-$78, signaling bearish momentum
Sentiment & News
Key News Insights:
- •Q1 growth
- •Fitch rating
- •Customer win
DBD's latest updates point to improving fundamentals, with Q1 revenue/EPS/FCF growth, a first-time BB- rating, and a new customer win despite some shareholder selling.
The news is modestly positive for DBD, reinforcing an improving execution story and supporting the investment case if cash generation continues
Similar Companies in Technology
Other companies in the same sector with AI ratings